The interaction between taxoids and serine/threonine protein phosphatase activities during taxan-induced apoptosis of HL 60 leukemic cells

References

• Cansolini R, Pui CH, Behm FG, Raimondi SC, Campana D. In vitro cytotoxicity of docetaxel in childhood acute leukemias. J Clin Oncol 1998; 16: 907–913.
   PubMed Web of Science ®Google Scholar
• Riou JF, Naudin A, Lavelle F. Effects of Taxotere on murine andhuman tumor cell lines. Biochem Biophys Res Commun 1992; 187: 164–170.
   PubMed Web of Science ®Google Scholar
• Hill BT, Whelan RDH, Shellard SA, McClean S, Hosking LK. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro. Invest New Drugs 1994; 12: 169–182.
   Google Scholar
• Bissery MC. Preclinical pharmacology of docetaxel. Eur J Cancer1995; 31 (Suppl. 4): S1–S6.
   Google Scholar
• Verweij J, Clavel M, Chevalier B. Paclitaxel (taxol) and docetaxel (taxotere): not simply two of kind. Ann Oncol 1994; 5: 495–505.
   PubMed Web of Science ®Google Scholar
• Rowinsky EK, Burke PJ, Karp JE, Tucker RW, Ettinger DS, Donehower RC. Phase I and pharmacodynamic study of taxol in refractory acute leukemias. Cancer Res 1989; 49: 4640–4647.
   PubMed Web of Science ®Google Scholar
• Lavelle F, Bissery MC, Combeau C, Riou JF, Vrignaud P, AndréS. Preclinical evaluation of docetaxel (Taxotere). Semin Oncol 1995; 22: 3–16.
   Web of Science ®Google Scholar
• Pronk LC, Stoter G, Verweij J. Docetaxel (Taxotere): single agentactivity, development of combination treatment and reducing side-effects. Cancer Treat Rev 1995; 21: 463–478.
   PubMed Web of Science ®Google Scholar
• Braakhuis BJM, Hill BT, Dietel M et al. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells. Anticancer Res 1994; 14: 205–208.
   PubMed Web of Science ®Google Scholar
• Saydam G, Aydin HH, Sahin F et al. Involvement of protein phosphatase 2A in interferon-α-2b induced apoptosis in K562 human chronic myelogenous leukaemia cells. Leuk Res 2003; 27: 709–717.
   PubMed Web of Science ®Google Scholar
• Uzunoglu S, Uslu R, Tobu M et al. Augmentation of methyl-prednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors. Leuk Res 1999; 23: 507.
   PubMed Web of Science ®Google Scholar
• Aydin HH, Selvi N, Saydam G et al. Up-regulation of serine/ threonine protein phosphatase type 2A regulatory subunits during methylprednisolone-induced differentiation of leukaemic HL-60 cells. Clin Lab Haem 2000; 22: 271.
   PubMedGoogle Scholar
• Wang LG, Liu XM, Kreis W, Budman DR. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 1999; 44: 355–361.
   PubMed Web of Science ®Google Scholar
• Haldar S, Jena N, Croce CM. Inactivation of bc1-2 by phosphor-ylation. Proc Nat/ Acad Sci USA 1995; 92: 4507
   PubMed Web of Science ®Google Scholar
• Brichese L, Valette A. PP1 phosphatase is involved in Bc1-2 dephosphorylation after prolonged mitotic arrest induced by paclitaxel. Biochem Biophys Res Commun 2002; 294: 504–508.
   PubMed Web of Science ®Google Scholar
• Yuksel S, Saydam G, Uslu R et al. Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation. Leuk Res 2002; 26: 391–398.
   PubMed Web of Science ®Google Scholar
• Cohen PT. Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem Sci 1997; 22: 245–251.
   PubMed Web of Science ®Google Scholar
• Klumpp S, Krieglstein J. Serine/threonine protein phosphatases in apoptosis. Curr Opin Pharmacol 2002; 2: 458–462.
   PubMed Web of Science ®Google Scholar
• Omay SB, Nishikawa M. Leukemic cell differentiation and signal transduction system. Turk J Haematol 2000; 17: 53–59.
   Google Scholar
• Cohen PT. Nomenclature and chromosomal localization of human protein serine/threonine phosphatase genes. Adv Prot Phosphatases 1994; 8: 371–376.
   Google Scholar
• Ingebritsen TS, Cohen P. Protein phosphatases: properties and rolein cellular regulation. Science 1983; 221: 331–338.
   PubMed Web of Science ®Google Scholar
• Ruvolo PP, Deng X, Ito T, Carr BK, May WS. Ceramide induces Bc12 dephosphorylation via a mechanism involving mitochondrial PP2A. J Biol Chem 1999; 274: 20296–20300.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Ichijo Si, Korsmeyer Si. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G2/M. Mol Cell Biol 1999; 19: 8469–8478.
   PubMed Web of Science ®Google Scholar
• Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer Si. Bad, a heterodimeric partner for Bc1-XL and Bc1-2, displaces Bax and prometes cell death. Cell 1995; 80: 2285–2291.
   Web of Science ®Google Scholar
• Ayllon V, Martinez AC, Garcia A, Cayla X, Robello A. Protein phosphatase 1α is a Ras-activated BAD phosphatase that regulates interleukin-2 deprivation-induced apoptosis. EMBO J 2000; 19: 2237–2246.
   PubMed Web of Science ®Google Scholar
• Chiang CW, Harris G, Ellig C et al. Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin-3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. Blood 2001; 97: 1289–1297.
   PubMed Web of Science ®Google Scholar
• Wang HG, Pathan N, Ethell IM et al. Ca2±-induced apoptosis through calcineurin dephosphorylation of BAD. Science 1999; 284: 339–343.
   PubMed Web of Science ®Google Scholar
• Desagher S, Osen-Sand A, Montessuit S et al. Phosphorylation of Bid by casein kinases I and II regulates its cleavage by caspase 8. Mol Cell 2001; 8: 601–611.
   PubMed Web of Science ®Google Scholar
• Santoro MF, Anannd RR, Robertson MM et al. Regulation of protein phosphatase 2A activity by caspase-3 during apoptosis. J Biol Chem 1998; 273: 13119–13123.
   PubMed Web of Science ®Google Scholar
• Mukerjee N, McGinnis KM, Gnegy ME, Wang KK. Caspase-mediated calcineurin activation contributes to IL-2 release during T cell activation. Biochem Biophys Res Commun 2001; 285: 1192–1199.
   PubMed Web of Science ®Google Scholar
• Schontal AH. Regulation of gene expression by serine/threonine protein phosphatases. Semin Cancer Biol 1995; 6: 239–248.
   PubMed Web of Science ®Google Scholar
• Gause KC, Homma MK, Licciardi KA et al. Effects of phorbol esther on mitogen-activated protein kinase kinase activity in wild-type and phorbol esther-resistant EL-4 thymoma cells. J Biol Chem 1993; 268: 16124–16129.
   PubMed Web of Science ®Google Scholar
• Millward TA, Zolnierowicz S, Hemming BA. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999; 24: 186–191.
   PubMed Web of Science ®Google Scholar
• Sontag E, Federov S, Kamibayashi C, Robbins D, Cobb M, Mumby M. The interaction of 5V40 small tumor antigen with protein phosphatase 2A stimulates the MAP kinase pathway and induces cell proliferation. Cell 1993; 75: 887–897.
   PubMed Web of Science ®Google Scholar
• Baksh S, DeCaprio JA, Burakoff Si. Calcineurin regulation of the mammalian G0/G1 checkpoint element, cyclin dependent kinase. Oncogene 2000; 19: 2820–2827.
   PubMed Web of Science ®Google Scholar
• Tamura S, Toriumi S, Saito J, Awano K, Kudo T, Kobayashi T. PP2C family members play key roles in regulation of cell survival and apoptosis. Cancer Sci 2006; 97: 563–567.
   PubMed Web of Science ®Google Scholar
• Lin FC, Arndt KT. The role of Saccharomyces cerevisiae type 2A phosphatase in the actin cytoskeleton and in entry into mitosis. EMBO J 1995; 14: 2745–2759.
   PubMed Web of Science ®Google Scholar
• Booher R, Beach D. Involvement of a type 1 protein phosphatase encoded by bwsl + in fission yeast mitotic control. Cell 1989; 57: 1009–1016.
   PubMed Web of Science ®Google Scholar
• Tournebize R, Andersen SS, Verde F, Doree M, Karsenti E, Hyman AA. Distinct roles of PP1 and PP2A-like phosphatases in control of microtubule dynamics during mitosis. EMBO J 1997; 16: 5537–5549.
   PubMed Web of Science ®Google Scholar
• Gligorov J, Lotz JP. Preclinical pharmacology of the taxanes: implications of the differences. Oncologist 2004; 9 (Suppl. 2): S3—S8.
   Google Scholar
• Haldar S, Basu A, Croce CM. Bc12 is the guardian of microtubuleintegrity. Cancer Res 1997; 57: 229–233.
   PubMed Web of Science ®Google Scholar